Papers associated with left (and grin2a)

Limit to papers also referencing gene:
Show all left papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.
	A convergent molecular network underlying autism and congenital heart disease., Rosenthal SB., Cell Syst. November 17, 2021; 12 (11): 1094-1107.e6.
	An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups., Perszyk R., Elife. May 24, 2018; 7
	Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology., Ogden KK., PLoS Genet. January 17, 2017; 13 (1): e1006536.
	MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit., Volkmann RA., PLoS One. January 1, 2016; 11 (2): e0148129.
	Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating., Sobolevsky AI., J Gen Physiol. June 1, 2007; 129 (6): 509-25.
	PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating., Lin Y., Proc Natl Acad Sci U S A. December 26, 2006; 103 (52): 19902-7.
	Na(+) occupancy and Mg(2+) block of the n-methyl-d-aspartate receptor channel., Zhu Y., J Gen Physiol. March 1, 2001; 117 (3): 275-86.
	Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+., Wollmuth LP., J Physiol. January 1, 1998; 506 ( Pt 1) 13-32.

???pagination.result.page??? 1